This positive decision, and the previous Therapeutic Goods Administration approval in Australia, were based on results from the phase III READY (RElabotulinumtoxin Aesthetic Development StudY) ...

Please provide your email address to receive an email when new articles are posted on . Relfydess has received a positive decision for treatment of frown lines and crow’s feet in the European Union.

In the past year or so, people have been increasingly outspoken about suspicions that their injectors are “watering down” ...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it presented new data from its Injectable Aesthetics portfolio and pipeline at ...